Point72 Hong Kong’s Celularity CELU Stock Holding History

Point72 Hong Kong’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,523	Closed	-$35K	–	329
2022 Q3	$35K	Buy	1,523 +1,104	+263%	+$33.5K	﹤0.01%	1513
2022 Q2	$14K	Buy	+419	New	+$34K	﹤0.01%	1622

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Point72 Hong Kong's CELU Position: Q4 2022 in Review

Point72 Hong Kong sold out of Celularity (CELU) in Q4 2022, closing a stake of 1,523 shares — an estimated $35K sold.

Point72 Hong Kong first reported a position in CELU in Q2 2022 and held it in 2 quarters. The position peaked at $35K in Q3 2022. 73 funds tracked by Wall St. Rank hold CELU as of Q4 2022.

Point72 Hong Kong reported no remaining Celularity position as of Q4 2022 after selling out during the quarter.
Point72 Hong Kong sold 1,523 Celularity shares in Q4 2022, an estimated $35K.
Point72 Hong Kong first reported a position in Celularity in Q2 2022 and held it in 2 quarters.
Point72 Hong Kong's Celularity position peaked at $35K in Q3 2022.
73 funds tracked by Wall St. Rank held Celularity as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.